🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We need to work together to get the therapies that people with #sicklecelldisease need! Today we meet at the The White House to discuss #genetherapy so we can get #SCD transformed!! #WhiteHouseCGT

CHOP's Dr. Stephan Grupp was invited to participate in the White House Cell and Gene Therapy Forum this week to discuss innovative approaches for advancing cell and gene therapy development, along with issues related to patient access and affordability. #WhiteHouseCGT

Amazing The Philadelphia Orchestra concert tonight with Yannick Nezet-Seguin and Yuja Wang doing the Tchaikovsky Piano Concerto #1. Wonderful performance and Wang encore. Played the crowd’s standing ovation as well as the Concerto.

Our Cell Therapy and Transplant group at Cancer Center @ CHOP always looks forward to the annual Alex's Lemonade Stand Foundation Lemon Ball. Always an amazing event, always so great to hear from the heroes and from Liz and Jay Scott. Caroline Diorio Regina Myers

Many of you made Alex's birthday extra special this year by celebrating The 19th Annual Lemon Ball with us! To the more than 500 attendees and sponsors, we can't thank you enough for making this event so sweet. With your help, we raised more than $870,000! This is enough to fund

Large long term CAR T safety data: -426 adults and 357 kids -tiny risk of 2nd cancers overall and lower in kids -lineage switch isn't a 2nd primary malignancy -many pts with long-term CAR persistence -many children in long term response/persistence category Cancer Center @ CHOP

Our Center recently celebrated its 600th patient treated with CAR T-cell immunotherapy, a groundbreaking “living drug” that utilizes the patient’s immune system to fight cancer. Pioneered at CHOP and Penn Medicine, CAR T has transformed cancer treatment worldwide.

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above

This is 100% on brand for this lawless administration, dropping this bomb in the midst of everyone’s ongoing biomedical research without any warning or ability to prepare. Folks who were hoping for new gene therapies, new cancer therapies, new Alzheimers insights…not happening

Why isn’t PA on the list of states suing to reverse this policy? Josh Shapiro Eugene DePasquale U.S. Senator John Fetterman U Penn Cancer Center @ CHOP CHOP Research

This is only the beginning of the consequences for the Senator’s vote to confirm RFKJr

In this Journal of Clinical Oncology editorial, the author discusses two studies by CHOP's Dr. Ted Laetsch, emphasizing importance of precision medicine treatments that target specific genetic makeup of cancers, promising improved outcomes and reduced toxicity for patients: ms.spr.ly/6017qnfgJ.

Just when you thought it couldn’t get any worse… It does. U Mich going beyond being forced into this to fully celebrating it.

Congratulation to the 2025 class of Fellows of the AACR Academy including Stand Up To Cancer community members Dr. Nina Bhardwaj Icahn School of Medicine at Mount Sinai, Stephan Grupp MD PhD Penn Medicine - Abramson Cancer Center, Ari Melnick Weill Cornell Medicine, William Sellers Broad Institute and Robert Vonderheide Penn Medicine - Abramson Cancer Center!!

New #JITC article: CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy bit.ly/3EDIVJu Marco Ruella @gruppsteve Regina Myers Caroline Diorio

🎻This was shown today at Cellicon Valley in the USA! It’s coming out tomorrow! “Ring That Bell”. Thank you all so much❤️ Thanks to all the scientists, doctors and nurses for all you.

Congratulations, Bruce, this is fantastic news and so well deserved!